ARDX
Ardelyx Inc
Price:  
3.60 
USD
Volume:  
5,999,508.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-168.4%
Upside

As of 2025-06-15, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -27.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 981.83 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -35.69 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.1x - 12.4x 10.2x
Forward P/E multiples 11.5x - 20.5x 16.0x
Fair Price (2.22) - (2.35) (2.46)
Upside -161.6% - -165.4% -168.4%
3.60 USD
Stock Price
(2.46) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-12 -28.92
2025-06-11 -28.18
2025-06-10 -28.45
2025-06-09 -28.58
2025-06-06 -28.05
2025-06-05 -27.78
2025-06-04 -28.12
2025-06-03 -29.72
2025-06-02 -29.19
2025-05-30 -27.98
2025-05-29 -30.40
2025-05-28 -29.59
2025-05-27 -29.99
2025-05-23 -29.99
2025-05-22 -29.93
2025-05-21 -30.13
2025-05-20 -31.40
2025-05-19 -30.60
2025-05-16 -29.39
2025-05-15 -26.04
2025-05-14 -25.37
2025-05-13 -26.10
2025-05-12 -27.04
2025-05-09 -27.65
2025-05-08 -27.78
2025-05-07 -28.18
2025-05-06 -29.86
2025-05-05 -28.42
2025-05-02 -31.07
2025-05-01 -40.05
2025-04-30 -40.28
2025-04-29 -39.92
2025-04-28 -39.24
2025-04-25 -38.64
2025-04-24 -37.03
2025-04-23 -35.89
2025-04-22 -35.62
2025-04-21 -33.95
2025-04-17 -35.66
2025-04-16 -34.22
2025-04-15 -34.48
2025-04-14 -34.02
2025-04-11 -33.28
2025-04-10 -31.87
2025-04-09 -33.55
2025-04-08 -32.41
2025-04-07 -33.21
2025-04-04 -33.88
2025-04-03 -35.16
2025-04-02 -36.09